2026 Half-Year Financial Report
news
2026 Half-Year Financial Report
More to Read
news
Oxide Computer Company and Carahsoft Partner to Bring On-Premise Cloud Computing to the Public Sector
The Oxide Cloud Computer, Purpose-Built Rack-Scale Infrastructure, Now Available to Government Agencies Through Carahsoft and Its Reseller Partners EMERYVILLE, Calif. and RESTON, Va., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Oxide Computer Company , the on-premise cloud computing company, and Carahsoft Technology Corp. , The Trusted Government IT Solutions Provider ® , today announced a partnership. Carahsoft will act as Oxide’s Master Government Aggregator ® , to make the Oxide Cloud Computer availab
news
ABC Arbitrage: Release of the half-year financial report as of June 30, 2026
ABC Arbitrage Release of the half-year financial report as of June 30, 202 6 ABC arbitrage announces that as of today its financial report for the first half of 2026 has been publicly released and filed with the Autorité des Marchés Financiers (AMF). This document includes the following parts: The half-year management report The half-year consolidated financial statements The statutory auditors’ report Statement by the person responsible for the financial report The annual financial report can b
news
ROBERTET GROUP - INTERIM CONSOLIDATED FINANCIAL STATEMENTS - HALF-YEAR 2026
ROBERTET GROUP - INTERIM CONSOLIDATED FINANCIAL STATEMENTS - HALF-YEAR 2026
news
AppFolio and Column Announce Strategic Partnership to Transform Financial Operations for Real Estate
Partnership brings Column’s next-generation banking capabilities within the AppFolio Performance Platform, helping property managers run their finances with confidence SANTA BARBARA, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- AppFolio (NASDAQ: APPF), the technology leader powering the future of the real estate industry, today named Column N.A. , Member FDIC, a nationally chartered bank built for modern fiduciaries, as its featured banking partner, an exclusive designation. Through the partnershi
news
Mortgage Rates Average 7.03%
Primary Mortgage Market Survey® U.S. weekly average mortgage rates as of 09/24/2026 MCLEAN, Va., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey ® (PMMS ® ), showing the 30-year fixed-rate mortgage (FRM) averaged 7.03%. “The housing market remains supported by a solid labor market and an economy that is growing at a healthy rate,” said Sam Khater, Freddie Mac's Chief Economist. News Facts The 30-year FRM averaged 7.03%
news
OpenZeppelin Integrates with TRON to Bring Its Security Standard to the Network
LONDON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- OpenZeppelin, the security standard for onchain finance and secure smart contract development, today announced that its smart contract libraries and secure development suite are now available for the TRON network. The integration gives developers building on TRON access to OpenZeppelin’s widely used security-focused development framework, adapted specifically for the TRON network. Teams can now build applications using audited contract components, famil
news
Availability of Transgene’s Half-Year Financial Report as of June 30, 2026
Strasbourg, September 24, 2026, 5:45 pm CET TRANSGENE (Paris: TNG) today announced that it has made available to the public and filed with the Autorité des marchés financiers its half-year financial report as of June 30, 2026. The document is available on the Company’s website: www.transgene.fr , in the “Investors/Financial information” section. This report comprises the following documents: 2026 half-year financial statements; Half-year management report; Statutory Auditors’ report on the 2026
news
Transgene Extends its myvac® Platform, Further Establishing its Position as a Key Player in the Rapidly Emerging Individualized Cancer Immunotherapy Field
2026 Half-Year Results and Business Update myvac ® – Expanding potential across solid tumors through viral vector, AI driven neoantigen selection, and scalable cell-line manufacturing TG4050 – First Individualized Neoantigen Therapeutic Vaccine (INTV) from the myvac ® platform advancing in resected HNSCC 1 Randomized Phase 1 data published in Nature Communications; Sustained 100% disease-free survival (DFS) after more than 3 years of follow-up, showing durable clinical outcomes and potential to
Comments (0)
Login to join the conversation
Login / RegisterNo comments yet. Be the first to comment!